Redefining a sexual medicine paradigm: subclinical premature ejaculation as a new taxonomic entity.


Journal

Nature reviews. Urology
ISSN: 1759-4820
Titre abrégé: Nat Rev Urol
Pays: England
ID NLM: 101500082

Informations de publication

Date de publication:
02 2021
Historique:
accepted: 02 12 2020
pubmed: 15 1 2021
medline: 31 8 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Premature ejaculation (PE) and poor ejaculatory control are multidimensional sexual symptoms estimated to affect almost one-third of men, severely impairing the overall quality of life of patients and their partners. However, patients who do not completely fulfil the definition criteria for PE rarely receive a diagnosis or adequate treatment, with the risk of subsequent progression from initial, subclinical symptoms to clinically overt PE, frequently with other sexual comorbidities. Thus, the current definitions of PE warrant review, in order to consider and propose a new taxonomy encompassing other unaddressed, crucial clinical aspects of PE. These newly proposed criteria include the recommendation for a primary screening for erectile dysfunction (ED), as PE and ED can be comorbid in up to 50% of patients but have never before been considered as a unified clinical entity. In order to facilitate clinical practice and improve clinical management of men with PE and comorbid conditions, we propose and define the new taxonomic clinical entities of subclinical PE (SPE) and loss of control of erection and ejaculation (LCEE). Application of these diagnoses to men who meet the criteria for SPE and/or LCEE, but not the overt conditions, could improve access to treatment for these patients and reduce progression to the more serious clinical disorder.

Identifiants

pubmed: 33442049
doi: 10.1038/s41585-020-00417-1
pii: 10.1038/s41585-020-00417-1
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-127

Références

Jannini, E. A. & Lenzi, A. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping. World J. Urol. 23, 68–75 (2005).
pubmed: 15902473 doi: 10.1007/s00345-004-0486-9
Serefoglu, E. C. et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. J. Sex. Med. 8, 540–548 (2011).
pubmed: 21054799 doi: 10.1111/j.1743-6109.2010.02095.x
Laumann, E. O., Paik, A. & Rosen, R. C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281, 537–544 (1999).
doi: 10.1001/jama.281.6.537 pubmed: 10022110
Laumann, E. O. et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the global study of sexual attitudes and behaviors. Int. J. Impot. Res. 17, 39–57 (2005).
pubmed: 15215881 doi: 10.1038/sj.ijir.3901250
Nolazco, C. et al. Prevalence of sexual dysfunctions in Argentina. Int. J. Impot. Res. 16, 69–72 (2004).
pubmed: 14963474 doi: 10.1038/sj.ijir.3901140
Tang, W. S. & Khoo, E. M. Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study. J. Sex. Med. 8, 2071–2078 (2011).
pubmed: 21492404 doi: 10.1111/j.1743-6109.2011.02280.x
Basile Fasolo, C. et al. Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001 — a study of the Italian society of andrology (SIA). J. Sex. Med. 2, 376–382 (2005).
pubmed: 16422869 doi: 10.1111/j.1743-6109.2005.20350.x
Porst, H. et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur. Urol. 51, 816–823 (2007).
pubmed: 16934919 doi: 10.1016/j.eururo.2006.07.004
Patrick, D. et al. Premature ejaculation: an observational study of men and their partners. J. Sex. Med. 2, 358–367 (2005).
pubmed: 16422867 doi: 10.1111/j.1743-6109.2005.20353.x
Giuliano, F. et al. Premature ejaculation: results from a five-country European observational study. Eur. Urol. 53, 1048–1057 (2008).
pubmed: 17950985 doi: 10.1016/j.eururo.2007.10.015
Montorsi, F. Prevalence of premature ejaculation: a global and regional perspective. J. Sex. Med. 2, 96–102 (2005).
pubmed: 16422795 doi: 10.1111/j.1743-6109.2005.20369.x
Jannini, E. A. et al. Premature ejaculation: old story, new insights. Fertil. Steril. 104, 1061–1073 (2015).
pubmed: 26409323 doi: 10.1016/j.fertnstert.2015.08.035
Althof, S. E. et al. An update of the International Society of Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE). Sex. Med. 2, 60–90 (2014).
pubmed: 25356302 pmcid: 4184677 doi: 10.1002/sm2.28
Jannini, E. A., Maggi, M. & Lenzi, A. Evaluation of premature ejaculation. J. Sex. Med. 8, 328–334 (2011).
pubmed: 21554554 doi: 10.1111/j.1743-6109.2011.02289.x
Schapiro, B. Premature ejaculation: a review of 1130 cases. J. Urol. 50, 374–379 (1943).
doi: 10.1016/S0022-5347(17)70462-4
Jannini, E. A., Simonelli, C. & Lenzi, A. Disorders of ejaculation. J. Endocrinol. Invest. 25, 1006–1019 (2002).
pubmed: 12553564 doi: 10.1007/BF03344077
Cihan, A. et al. The relationship between premature ejaculation and hyperthyroidism. J. Urol. 181, 1273–1280 (2009).
pubmed: 19185321 doi: 10.1016/j.juro.2008.10.150
Cahangirov, A. et al. Investigation of the neural target level of hyperthyroidism in premature ejaculation in a rat model of pharmacologically induced ejaculation. J. Sex. Med. 8, 90–96 (2011).
pubmed: 20946168 doi: 10.1111/j.1743-6109.2010.02042.x
Carani, C. et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J. Clin. Endocrinol. Metab. 90, 6472–6479 (2005).
pubmed: 16204360 doi: 10.1210/jc.2005-1135
McMahon, C. G., Jannini, E. A., Serefoglu, E. C. & Hellstrom, W. J. The pathophysiology of acquired premature ejaculation. Transl. Androl. Urol. 5, 434–449 (2016).
pubmed: 27652216 pmcid: 5001985 doi: 10.21037/tau.2016.07.06
Screponi, E. et al. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58, 198–202 (2001).
pubmed: 11489699 doi: 10.1016/S0090-4295(01)01151-7
Waldinger, M. D. The neurobiological approach to premature ejaculation. J. Urol. 168, 2359–2367 (2002).
pubmed: 12441918 doi: 10.1016/S0022-5347(05)64146-8
Colpi, G. M., Fanciullacci, F., Beretta, G., Negri, L. & Zanollo, A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia 18, 583–586 (1986).
pubmed: 3813046 doi: 10.1111/j.1439-0272.1986.tb01834.x
Janssen, P. K., Zwinderman, A. H., Olivier, B. & Waldinger, M. D. Serotonin transporter promoter region (5-HTTLPR) polymorphism is not associated with paroxetine-induced ejaculation delay in dutch men with lifelong premature ejaculation. Korean J. Urol. 55, 129–133 (2014).
pubmed: 24578810 pmcid: 3935070 doi: 10.4111/kju.2014.55.2.129
Salonia, A. et al. Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study. J. Sex. Med. 6, 1755–1762 (2009).
pubmed: 19453912 doi: 10.1111/j.1743-6109.2009.01276.x
Buvat, J. Pathophysiology of premature ejaculation. J. Sex. Med. 8, 316–327 (2011).
pubmed: 21967394 doi: 10.1111/j.1743-6109.2011.02384.x
Jannini, E. A., McCabe, M. P., Salonia, A., Montorsi, F. & Sachs, B. D. Organic vs. psychogenic? The Manichean diagnosis in sexual medicine. J. Sex. Med. 7, 1726–1733 (2010).
pubmed: 20537061 doi: 10.1111/j.1743-6109.2010.01824.x
Rowland, D. L., Patrick, D. L., Rothman, M. & Gagnon, D. D. The psychological burden of premature ejaculation. J. Urol. 177, 1065–1070 (2007).
pubmed: 17296413 doi: 10.1016/j.juro.2006.10.025
McMahon, C. G. Current and emerging treatments for premature ejaculation. Sex. Med. Rev. 3, 183–202 (2015).
pubmed: 27784609 doi: 10.1002/smrj.49
Prieto-Castro, R. et al. Opinions, attitudes, and perceptions in relation to erectile dysfunction and premature ejaculation in the undiagnosed spanish male population. Results of the PANDORA project. J. Sex. Med. 17, 1495–1508 (2020).
pubmed: 32622766 doi: 10.1016/j.jsxm.2020.04.381
Wijesinha, S., Piterman, L. & Kirby, C. N. The male reproductive system — An overview of common problems. Aust. Fam. Physician 42, 276–278 (2013).
pubmed: 23781524
Vik, A. & Brekke, M. Do patients consult their GP for sexual concerns? A cross sectional explorative study. Scand. J. Prim. Health Care 35, 373–378 (2017).
pubmed: 29105541 pmcid: 5730036 doi: 10.1080/02813432.2017.1398934
Nazareth, I., Boynton, P. & King, M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ 327, 423 (2003).
pubmed: 12933729 pmcid: 181260 doi: 10.1136/bmj.327.7412.423
Burgio, G. et al. Evaluation of the mistakes in self-diagnosis of sexual dysfunctions in 11,000 male outpatients: a real-life study in an andrology clinic. J. Clin. Med. 8, 1679 (2019).
pmcid: 6832924 doi: 10.3390/jcm8101679
Gross, S. W. A Practical Treatise on Impotence, Sterility and Allied Disorders of the Male Sexual Organs 2nd edn (H. C. Lea’s Son & Co., 1883).
Jannini, E. A. & Lenzi, A. Epidemiology of premature ejaculation. Curr. Opin. Urol. 15, 399–403 (2005).
pubmed: 16205491 doi: 10.1097/01.mou.0000182327.79572.fd
Crow, B. A. Radical Reminism: A Documentary Reader (New York University Press, 2000).
Waldinger, M. D. in Premature Ejaculation. From etiology to diagnosis and treatment Ch. 2 (eds Jannini, E. A., McMahon, C. & Waldinger, M.) 5–24 (Springer-Verlag, 2013)
Jannini, E. A. et al. Who’s afraid of the G-spot? J. Sex. Med. 7, 25–34 (2010).
pubmed: 20092462 doi: 10.1111/j.1743-6109.2009.01613.x
Jannini, E. A. & Porst, H. A practical approach to premature ejaculation. Introduction: the asynchronous couple. J. Sex. Med. 8, 301–303 (2011).
pubmed: 21967391 doi: 10.1111/j.1743-6109.2011.02456.x
Hellstrom, W., Gittelman, M., Althof, S., Ho, K. F. & Kell, S. Dapoxetine HCl for the treatment of premature ejaculation: a phase II, randomized, double-blind, placebo-controlled study. J. Sex. Med. 1, 59–59 (2004).
Hellstrom, W. J. G. et al. 877: Dapoxetine for the treatment of men with premature ejaculation (PE): dose-finding analysis. J. Urol. 173, 238–238 (2005).
doi: 10.1016/S0022-5347(18)35046-8
McMahon C.G. et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J. Sex. Med. 5, 1590–1606 (2008).
pubmed: 18466262 doi: 10.1111/j.1743-6109.2008.00901.x
Althof S. et al. International Society for Sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation. J. Sex. Med. 7, 2947–2969 (2010).
pubmed: 21050394 doi: 10.1111/j.1743-6109.2010.01975.x
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
Waldinger, M. D. et al. A multinational population survey of intravaginal ejaculation latency time. J. Sex. Med. 2, 492–497 (2005).
pubmed: 16422843 doi: 10.1111/j.1743-6109.2005.00070.x
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR 4th edn (American Psychiatric Association, 2010).
Sansone, A., Romanelli, F., Jannini, E. A. & Lenzi, A. Hormonal correlations of premature ejaculation. Endocrine 49, 333–338 (2015).
pubmed: 25552341 doi: 10.1007/s12020-014-0520-7
Burri, A. & Graziottin, A. Cross-cultural differences in women’s sexuality and their perception and impact of premature ejaculation. Urology 85, 118–124 (2015).
pubmed: 25530374 doi: 10.1016/j.urology.2014.09.037
Shaeer, O. & Shaeer, K. The global online sexuality survey (GOSS): ejaculatory function, penile anatomy, and contraceptive usage among Arabic-speaking Internet users in the Middle East. J. Sex. Med. 9, 425–433 (2012).
pubmed: 21676184 doi: 10.1111/j.1743-6109.2011.02338.x
El-Sakka, A. I. in Cultural Differences and the Practice of Sexual Medicine. Trends in Andrology and Sexual Medicine. Ch. 8 (eds Rowland D. & Jannini E. A.) 135–148 (Springer International Publishing, 2020).
Jannini, E. A., Simonelli, C. & Lenzi, A. Sexological approach to ejaculatory dysfunction. Int. J. Androl. 25, 317–323 (2002).
pubmed: 12406363 doi: 10.1046/j.1365-2605.2002.00371.x
Sansone, A. et al. The sentiment analysis of tweets as a new tool to measure public perception of male erectile and ejaculatory dysfunctions. Sex. Med. 7, 464–471 (2019).
pubmed: 31395527 pmcid: 6963121 doi: 10.1016/j.esxm.2019.07.001
Serefoglu, E. C. et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation. Sex. Med. 2, 41–59 (2014).
pubmed: 25356301 pmcid: 4184676 doi: 10.1002/sm2.27
Masters, W. H. & Johnson, V. E. Human sexual inadequacy 1st edn (Little, 1970).
Rowland, D. L., Cooper, S. E. & Schneider, M. Defining premature ejaculation for experimental and clinical investigations. Arch. Sex. Behav. 30, 235–253 (2001).
pubmed: 11330115 doi: 10.1023/A:1002714812709
Bhat, G. S. & Shastry, A. Use of a stopwatch to measure ejaculatory latency may not be accurate among Indian patients. Indian J. Urol. 33, 300–303 (2017).
pubmed: 29021654 pmcid: 5635671 doi: 10.4103/iju.IJU_56_17
Waldinger, M. D. & Schweitzer, D. H. Method and design of drug treatment research of subjective premature ejaculation in men differs from that of lifelong premature ejaculation in males: proposal for a new objective measure (part 1). Int. J. Impot. Res. 31, 328–333 (2019).
pubmed: 30647430 doi: 10.1038/s41443-018-0107-6
Waldinger, M. D. & Schweitzer, D. H. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part II — proposals for DSM-V and ICD-11. J. Sex. Med. 3, 693–705 (2006).
pubmed: 16839326 doi: 10.1111/j.1743-6109.2006.00276.x
Montague, D. K. et al. AUA guideline on the pharmacologic management of premature ejaculation (reviewed and validity confirmed in 2010). J. Urol. 172, 290–294 (2004).
pubmed: 15201797 doi: 10.1097/01.ju.0000132159.61156.ea
Waldinger, M. D., Hengeveld, M. W., Zwinderman, A. H. & Olivier, B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int. J. Psychiatry Clin. Pract. 2, 287–293 (1998).
pubmed: 24927094 doi: 10.3109/13651509809115376
Althof, S. E. & Symonds, T. Patient reported outcomes used in the assessment of premature ejaculation. Urol. Clin. North. Am. 34, 581–589 (2007).
pubmed: 17983898 doi: 10.1016/j.ucl.2007.08.001
Symonds, T. et al. Development and validation of a premature ejaculation diagnostic tool. Eur. Urol. 52, 565–573 (2007).
pubmed: 17275165 doi: 10.1016/j.eururo.2007.01.028
Yuan, Y. M. et al. Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation. Asian J. Androl. 6, 121–126 (2004).
pubmed: 15154086
Althof, S. et al. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J. Sex. Med. 3, 465–475 (2006).
pubmed: 16681472 doi: 10.1111/j.1743-6109.2006.00239.x
Janssen, P. K. C. & Waldinger, M. D. Men with subjective premature ejaculation have a similar lognormal IELT distribution as men in the general male population and differ mathematically from males with lifelong premature ejaculation after an IELT of 1.5 minutes (Part 2). Int. J. Impot. Res. 31, 341–347 (2019).
pubmed: 31395985 doi: 10.1038/s41443-019-0172-5
Barbonetti, A. et al. Erectile dysfunction and premature ejaculation in homosexual and heterosexual men: a systematic review and meta-analysis of comparative studies. J. Sex. Med. 16, 624–632 (2019).
pubmed: 30926517 doi: 10.1016/j.jsxm.2019.02.014
Corty, E. W. Perceived ejaculatory latency and pleasure in different outlets. J. Sex. Med. 5, 2694–2702 (2008).
pubmed: 18638007 doi: 10.1111/j.1743-6109.2008.00939.x
Strassberg, D. S., Kelly, M. P., Carroll, C. & Kircher, J. C. The psychophysiological nature of premature ejaculation. Arch. Sex. Behav. 16, 327–336 (1987).
pubmed: 3675186 doi: 10.1007/BF01542142
Rowland, D. L., Strassberg, D. S., de Gouveia Brazao, C. A. & Slob, A. K. Ejaculatory latency and control in men with premature ejaculation. J. Psychosom. Res. 48, 69–77 (2000).
pubmed: 10750632 doi: 10.1016/S0022-3999(99)00078-1
Limoncin, E. et al. The Masturbation Erection Index (MEI): validation of a new psychometric tool, derived from the six-item version of the International Index of Erectile Function (IIEF-6) and from the Erection Hardness Score (EHS), for measuring erectile function during masturbation. BJU Int. 123, 530–537 (2019).
pubmed: 30255975 doi: 10.1111/bju.14560
Waldinger, M. D. Four measures of investigating ejaculatory performance. J. Sex. Med. 4, 520 (2007).
pubmed: 17367448 doi: 10.1111/j.1743-6109.2007.00443_2.x
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (10th Revision) (World Health Organization, 1994).
Colpi, G. et al. EAU guidelines on ejaculatory dysfunction. Eur. Urol. 46, 555–558 (2004).
pubmed: 15474262 doi: 10.1016/j.eururo.2004.07.020
Salonia, A. et al. EAU guidelines on male sexual dysfunction: disorders of ejaculation. Presented at the EAU Annual Congress Amsterdam (2020).
Derogatis, L. R. et al. Responses to the proposed DSM-V changes. J. Sex. Med. 7, 1998–2014 (2010).
pubmed: 20929516 doi: 10.1111/j.1743-6109.2010.01865.x
World Health Organization. International Classification of Diseases for Mortality and Morbidity Statistics (11th Revision) (World Health Organization, 2019).
Waldinger, M. D. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int. J. Impot. Res. 15, 309–313 (2003).
pubmed: 14562129 doi: 10.1038/sj.ijir.3901023
Son, H., Song, S. H., Kim, S. W. & Paick, J. S. Self-reported premature ejaculation prevalence and characteristics in Korean young males: community-based data from an internet survey. J. Androl. 31, 540–546 (2010).
pubmed: 20671139 doi: 10.2164/jandrol.110.010355
Colonnello, E. & Jannini, E. A. in Cultural Differences and the Practice of Sexual Medicine Trends in Andrology and Sexual Medicine Ch. 6 (eds Rowland, D. & Jannini, E. A.) 95–113 (Springer International Publishing, 2020).
Rosen, R. C. & Althof, S. Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J. Sex. Med. 5, 1296–1307 (2008).
pubmed: 18422496 doi: 10.1111/j.1743-6109.2008.00825.x
Symonds, T., Roblin, D., Hart, K. & Althof, S. How does premature ejaculation impact a man’s life? J. Sex. Marital. Ther. 29, 361–370 (2003).
pubmed: 14504007 doi: 10.1080/00926230390224738
Riley, A. & Riley, E. Premature ejaculation: presentation and associations. An audit of patients attending a sexual problems clinic. Int. J. Clin. Pract. 59, 1482–1487 (2005).
pubmed: 16351684 doi: 10.1111/j.1368-5031.2005.00730.x
Graziottin, A. & Althof, S. What does premature ejaculation mean to the man, the woman, and the couple? J. Sex. Med. 8, 304–309 (2011).
pubmed: 21967392 doi: 10.1111/j.1743-6109.2011.02426.x
Byers, E. S. & Grenier, G. Premature or rapid ejaculation: heterosexual couples’ perceptions of men’s ejaculatory behavior. Arch. Sex. Behav. 32, 261–270 (2003).
pubmed: 12807298 doi: 10.1023/A:1023417718557
Hobbs, K., Symonds, T., Abraham, L., May, K. & Morris, M. F. Sexual dysfunction in partners of men with premature ejaculation. Int. J. Impot. Res. 20, 512–517 (2008).
pubmed: 18650826 doi: 10.1038/ijir.2008.34
Limoncin, E. et al. Premature ejaculation results in female sexual distress: standardization and validation of a new diagnostic tool for sexual distress. J. Urol. 189, 1830–1835 (2013).
pubmed: 23142691 doi: 10.1016/j.juro.2012.11.007
Bancroft, J., Carnes, L., Janssen, E., Goodrich, D. & Long, J. S. Erectile and ejaculatory problems in gay and heterosexual men. Arch. Sex. Behav. 34, 285–297 (2005).
pubmed: 15971011 doi: 10.1007/s10508-005-3117-7
Jern, P. et al. Subjectively measured ejaculation latency time and its association with different sexual activities while controlling for age and relationship length. J. Sex. Med. 6, 2568–2578 (2009).
pubmed: 19523034 doi: 10.1111/j.1743-6109.2009.01360.x
Shindel, A. W., Vittinghoff, E. & Breyer, B. N. Erectile dysfunction and premature ejaculation in men who have sex with men. J. Sex. Med. 9, 576–584 (2012).
pubmed: 22214402 pmcid: 3271132 doi: 10.1111/j.1743-6109.2011.02585.x
Mondaini, N. et al. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo”. Urology 82, 620–624 (2013).
pubmed: 23987156 doi: 10.1016/j.urology.2013.05.018
Waldinger, M. D. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J. Sex. Marital. Ther. 34, 1–13 (2008).
pubmed: 18396725 doi: 10.1080/00926230701640355
Parnham, A. & Serefoglu, E. C. Classification and definition of premature ejaculation. Transl. Androl. Urol. 5, 416–423 (2016).
pubmed: 27652214 pmcid: 5001991 doi: 10.21037/tau.2016.05.16
Martin-Tuite, P. & Shindel, A. W. Management options for premature ejaculation and delayed ejaculation in men. Sex. Med. Rev. 8, 473–485 (2020).
pubmed: 31668585 doi: 10.1016/j.sxmr.2019.09.002
Althof, S. E. Psychosexual therapy for premature ejaculation. Transl. Androl. Urol. 5, 475–481 (2016).
pubmed: 27652220 pmcid: 5001981 doi: 10.21037/tau.2016.05.15
Waldinger, M. D., McIntosh, J. & Schweitzer, D. H. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J. Sex. Med. 6, 2888–2895 (2009).
pubmed: 19627471 doi: 10.1111/j.1743-6109.2009.01392.x
Sansone, A. et al. Management of premature ejaculation: a clinical guideline from the Italian society of andrology and sexual medicine (SIAMS). J. Endocrinol. Invest. https://doi.org/10.1007/s40618-020-01458-4 (2020).
doi: 10.1007/s40618-020-01458-4 pubmed: 33128158 pmcid: 7355084
Melnik, T. et al. Psychosocial interventions for premature ejaculation. Cochrane Database Syst. Rev. 8, CD008195 (2011).
Gul, M. & Kaynar, M. Evaluating the content and quality of information about premature ejaculation on the Internet: what are men being exposed to? Andrologia 49, e12612 (2017).
doi: 10.1111/and.12612
Limoncin, E. et al. The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the ‘Orgasmometer’. Andrology 4, 921–926 (2016).
pubmed: 27214119 doi: 10.1111/andr.12220
Zhang, D. et al. Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol. 19, 2 (2019).
pubmed: 30606186 pmcid: 6318994 doi: 10.1186/s12894-018-0431-7
Corona, G. et al. Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. J. Sex. Med. 12, 2291–2300 (2015).
pubmed: 26552599 doi: 10.1111/jsm.13041
Kamnerdsiri, W. A., Rodriguez Martinez, J. E., Fox, C. & Weiss, P. Clinical correlation between erectile function and ejaculatory function in the Czech male population. PLoS ONE 13, e0199588 (2018).
pubmed: 30001388 pmcid: 6042713 doi: 10.1371/journal.pone.0199588
Jannini, E. A., Lombardo, F. & Lenzi, A. Correlation between ejaculatory and erectile dysfunction. Int. J. Androl. 28, 40–45 (2005).
pubmed: 16236063 doi: 10.1111/j.1365-2605.2005.00593.x
McMahon, C. G. Screening for erectile dysfunction in men with lifelong premature ejaculation — is the sexual health inventory for men (SHIM) reliable? J. Sex. Med. 6, 567–573 (2009).
pubmed: 19215618 doi: 10.1111/j.1743-6109.2008.01092.x
Morales, A., Barada, J. & Wyllie, M. G. A review of the current status of topical treatments for premature ejaculation. BJU Int. 100, 493–501 (2007).
pubmed: 17608824 doi: 10.1111/j.1464-410X.2007.07051.x
NIH Consensus Development Panel on Impotence. Impotence. JAMA 270, 83–90 (1993).
doi: 10.1001/jama.1993.03510010089036
Peeters, R. P. Subclinical hypothyroidism. N. Engl. J. Med. 376, 2556–2565 (2017).
pubmed: 28657873 doi: 10.1056/NEJMcp1611144
Fernandez-Alvira, J. M. et al. Predicting subclinical atherosclerosis in low-risk individuals: ideal cardiovascular health score and fuster-BEWAT score. J. Am. Coll. Cardiol. 70, 2463–2473 (2017).
pubmed: 29145946
Keuthen, N. J. et al. A comparison of clinical vs subclinical skin pickers in Israel. Ann. Clin. Psychiatry 28, 98–104 (2016).
pubmed: 27285390
Jannini, E. A., Lenzi, A., Isidori, A. & Fabbri, A. Subclinical erectile dysfunction: proposal for a novel taxonomic category in sexual medicine. J. Sex. Med. 3, 787–794 (2006).
pubmed: 16942523 doi: 10.1111/j.1743-6109.2006.00287.x
Mulhall, J. P. et al. The 2018 revision to the process of care model for management of erectile dysfunction. J. Sex. Med. 15, 1434–1445 (2018).
pubmed: 30057278 doi: 10.1016/j.jsxm.2018.05.021
Mulhall, J. P., Goldstein, I., Bushmakin, A. G., Cappelleri, J. C. & Hvidsten, K. Validation of the erection hardness score. J. Sex. Med. 4, 1626–1634 (2007).
pubmed: 17888069 doi: 10.1111/j.1743-6109.2007.00600.x
Mollaioli, D. et al. Validation of a visual analogue scale to measure the subjective perception of orgasmic intensity in females: the orgasmometer-F. PLoS ONE 13, e0202076 (2018).
pubmed: 30157203 pmcid: 6114295 doi: 10.1371/journal.pone.0202076
Waldinger, M. D. & Olivier, B. Animal models of premature and retarded ejaculation. World J. Urol. 23, 115–118 (2005).
pubmed: 15940532 doi: 10.1007/s00345-004-0493-x
Di Sante, S. et al. Epidemiology of delayed ejaculation. Transl. Androl. Urol. 5, 541–548 (2016).
pubmed: 27652226 pmcid: 5002002 doi: 10.21037/tau.2016.05.10
Porst, H. & Burri, A. Fortacin spray for the treatment of premature ejaculation. Urologia 84, 1–10 (2017).
pubmed: 30047847 pmcid: 6166492 doi: 10.5301/uj.5000275
European Medicines Agency. Fortacin. EMA https://www.ema.europa.eu/en/medicines/human/EPAR/fortacin (2020).
Carson, C. & Wyllie, M. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study. J. Sex. Med. 7, 3179–3189 (2010).
pubmed: 20584124 doi: 10.1111/j.1743-6109.2010.01913.x
Dinsmore, W. W. & Wyllie, M. G. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int. 103, 940–949 (2009).
pubmed: 19245438 doi: 10.1111/j.1464-410X.2009.08456.x
Porst, H. et al. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials. J. Sex. Med. 7, 2231–2242 (2010).
pubmed: 20412423 doi: 10.1111/j.1743-6109.2010.01820.x
Pryor, J. L. et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet 368, 929–937 (2006).
pubmed: 16962882 doi: 10.1016/S0140-6736(06)69373-2
Zhao, G. J., Guo, Q., Li, Y. F. & Zhang, Y. G. Efficacy and safety of dapoxetine for premature ejaculation: an updated systematic review and meta-analysis. Sex. Health 16, 301–313 (2019).
pubmed: 32172793 doi: 10.1071/SH18005
Reisman, Y. Sexual consequences of post-SSRI syndrome. Sex. Med. Rev. 5, 429–433 (2017).
pubmed: 28642048 doi: 10.1016/j.sxmr.2017.05.002
Jannini, E. A., Isidori, A. M., Aversa, A., Lenzi, A. & Althof, S. E. Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions. J. Sex. Med. 10, 2359–2369 (2013).
pubmed: 24112352 doi: 10.1111/jsm.12315
Jannini, E. A., McMahon, C., Chen, J., Aversa, A. & Perelman, M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J. Sex. Med. 8, 2135–2143 (2011).
pubmed: 21791006 doi: 10.1111/j.1743-6109.2011.02401.x
European Medicines Agency. Priligy. EMA https://www.ema.europa.eu/en/medicines/human/referrals/priligy (2012).
Dresser, M. J., Desai, D., Gidwani, S., Seftel, A. D. & Modi, N. B. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int. J. Impot. Res. 18, 104–110 (2006).
pubmed: 16307008 doi: 10.1038/sj.ijir.3901420
McMahon, C. G. et al. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study. J. Sex. Med. 10, 2312–2325 (2013).
pubmed: 23845016 doi: 10.1111/jsm.12236
Abu El-Hamd, M. & Abdelhamed, A. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia https://doi.org/10.1111/and.12829 (2018).
doi: 10.1111/and.12829 pubmed: 30411390
Tuken, M., Culha, M. G. & Serefoglu, E. C. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction-DAP-SPEED Study. Int. J. Impot. Res. 31, 92–96 (2019).
pubmed: 30705437 doi: 10.1038/s41443-019-0122-2
McMahon, C. G., McMahon, C. N., Leow, L. J. & Winestock, C. G. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: a systematic review. BJU Int. 98, 259–272 (2006).
pubmed: 16879663 doi: 10.1111/j.1464-410X.2006.06290.x
Wang, W. F., Minhas, S. & Ralph, D. J. Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation. Int. J. Androl. 29, 503–509 (2006).
pubmed: 16573707 doi: 10.1111/j.1365-2605.2006.00689.x
Aversa, A. et al. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int. J. Impot. Res. 21, 221–227 (2009).
pubmed: 19474796 doi: 10.1038/ijir.2009.21
El-Refai, K., Teaima, M. H. & El-Nabarawi, M. A. Dual-purpose vardenafil hydrochloride/dapoxetine hydrochloride orodispersible tablets: in vitro formulation/evaluation, stability study and in vivo comparative pharmacokinetic study in healthy human subjects. Drug Dev. Ind. Pharm. 44, 988–1000 (2018).
pubmed: 29325456 doi: 10.1080/03639045.2018.1427761
Moudi, E. & Kasaeeyan, A. A. Comparison between tadalafil plus paroxetine and paroxetine alone in the treatment of premature ejaculation. Nephrourol. Mon. 8, e32286 (2016).
pubmed: 26981497 pmcid: 4780280 doi: 10.5812/numonthly.32286
Bai, Y. et al. Selective serotonin reuptake inhibitors plus phosphodiesterase-5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Urology 86, 758–764 (2015).
pubmed: 26247816 doi: 10.1016/j.urology.2015.06.045
Sun, Y. et al. Efficacy of phosphodiesterase-5 inhibitor in men with premature ejaculation: a new systematic review and meta-analysis. Urology 86, 947–954 (2015).
pubmed: 26278825 doi: 10.1016/j.urology.2015.06.051
Men, C., Yu, L., Yuan, H. & Cui, Y. Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysis. Andrologia 48, 978–985 (2016).
pubmed: 26791333 doi: 10.1111/and.12540
Martyn-St James, M. et al. Phosphodiesterase type 5 inhibitors for premature ejaculation: a systematic review and meta-analysis. Eur. Urol. Focus. 3, 119–129 (2017).
pubmed: 28720356 pmcid: 5503121 doi: 10.1016/j.euf.2016.02.001
Sridharan, K., Sivaramakrishnan, G., Sequeira, R. P. & Al-Khaja, K. A. Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials. Int. J. Impot. Res. 30, 215–223 (2018).
pubmed: 29921893 doi: 10.1038/s41443-018-0030-x
Ciocca, G. et al. Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculation. Arab. J. Urol. 11, 305–312 (2013).
pubmed: 26558097 pmcid: 4443008 doi: 10.1016/j.aju.2013.04.011
Jannini, E. A. SM = SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Sex. Med. Rev. 5, 349–364 (2017).
pubmed: 28596070 doi: 10.1016/j.sxmr.2017.04.002
Jannini, E. A. & Nappi, R. E. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause. Sex. Med. Rev. 6, 384–395 (2018).
pubmed: 29371146 doi: 10.1016/j.sxmr.2017.11.002

Auteurs

Elena Colonnello (E)

Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Giacomo Ciocca (G)

Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Clinical Psychosexology, Department of Dynamic and Clinical Psychology, University of Rome Sapienza, Rome, Italy.

Erika Limoncin (E)

Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Andrea Sansone (A)

Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Emmanuele A Jannini (EA)

Endocrinology & Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. eajannini@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH